Faculty

Tisha N. Lunsford, M.D.

Clinical Studies

Open

Low-dose Growth Hormone for the Treatment of Gastroparesis Scottsdale/Phoenix, Ariz.
The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.

Closed for Enrollment

EPT-InF24-001: An Antibody Guided Dietary Restriction Trial Using Biomerica InFoods® IBS Test in Patients with a Previous Diagnosis of Irritable Bowel Syndrome (IBS) Scottsdale/Phoenix, Ariz.
The purposes of this study are to to evaluate the use of IgG antibody guided dietary restrictions, based on the Biomerica InFoods® IBS ELISA, in the management of patients diagnosed with Irritable Bowel Syndrome (IBS).

.

.